Correlation Between Scpharmaceuticals and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Scpharmaceuticals and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and NLS Pharmaceutics.
Diversification Opportunities for Scpharmaceuticals and NLS Pharmaceutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Scpharmaceuticals and NLS is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and NLS Pharmaceutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the NLS Pharmaceutics. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.42 times less risky than NLS Pharmaceutics. The stock trades about -0.14 of its potential returns per unit of risk. The NLS Pharmaceutics AG is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 386.00 in NLS Pharmaceutics AG on August 31, 2024 and sell it today you would lose (59.00) from holding NLS Pharmaceutics AG or give up 15.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Scpharmaceuticals |
| NLS Pharmaceutics |
Scpharmaceuticals and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and NLS Pharmaceutics
The main advantage of trading using opposite Scpharmaceuticals and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| NLS Pharmaceutics vs. Neurobo Pharmaceuticals | NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |